SCHEMBL6783250

SCHEMBL6783250

CCc1cc(Nc2cc(=O)[nH]c(=O)[nH]2)ccc1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.73
▸ MAPT P10636 1/20 0.58
▸ HTT P42858 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17057465 0.84 TP53 (1.00) TP53MAPTHTT
SCHEMBL3971657 0.81 UNG (0.60) TP53
SCHEMBL7533591 0.81 TP53 (0.75) TP53MAPTHTT
SCHEMBL5298937 0.78 TP53 (0.71) TP53MAPTHTT
SCHEMBL30320683 0.74 TP53 (0.69) TP53MAPTHTT
SCHEMBL5311067 0.74 TP53 (0.69) TP53MAPTHTT
SCHEMBL5309531 0.73 TP53 (0.63) TP53MAPTHTT
SCHEMBL11997016 0.72 KMT2A (0.50) —
SCHEMBL3471080 0.71 — —
SCHEMBL5940601 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401829-B1 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS MICROBIOTIX INC (US) 2012-08-22 — — EP disclosed
EP-1401829-A4 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS MICROBIOTIX INC (US) 2004-10-27 — — EP disclosed
US-6777420-B2 A URACIL COMPOUNDS AS ENZYME INHIBITORS, INHIBIT BACTERIAL DNA POLYMERASE, TREATING BACTERIAL DISEASES MICROBIOTIX, INC. 2004-08-17 — — US disclosed
EP-1401829-A1 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS Microbiotix, Inc. (US) 2004-03-31 — — EP disclosed
WO-2002102792-A1 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS MICROBIOTIX, INC. (US) 2002-12-27 — — WO disclosed
US-6448256-B1 PRECURSORS OF N-SUBSTITUTED DERIVATIVES OF 6-AMINOURACILS, 6-AMINOISOCYTOSINES, GUANINES AND 2-AMINOADENINES HAVING A CLEAVABLE ESTER GROUP; GREATER WATER SOLUBILITY AND ORAL BIOAVAILABILITY; TREATING GRAM POSITIVE BACTERIAL INFECTIONS UNIVERSITY OF MASSACHUSETTS 2002-09-10 — — US disclosed
EP-1185517-A1 ANTIBIOTIC PRODRUGS University of Massachusetts (US) 2002-03-13 — — EP disclosed
WO-2000071523-A1 ANTIBIOTIC PRODRUGS UNIVERSITY OF MASSACHUSETTS (US) 2000-11-30 — — WO disclosed
Send feedback